ARTHUR LAWRENCE REINGOLD

BERKELEY, CA

General Payments — all program years on this page

$25,946.23

  • Category: General Payments
  • Program years: PY2019–2023
  • Record count: 27
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $11,068.38 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $9,510.002
Travel and Lodging $1,293.256
Food and Beverage $265.134

By paying entity

Latest program year (PY2023) · sorted by reported total.

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $6,900.001
Merck Sharp & Dohme Corporation $4,168.3811

By program year

Program yearAmountRecords
2019 $4,293.7910
2020 $3,057.412
2021 $1,500.001
2022 $6,026.652
2023 $11,068.3812

Records — PY2023 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1048252441 Merck Sharp & Dohme LLC $231.57 11/28/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1048252509 Merck Sharp & Dohme LLC $387.16 11/28/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1048252511 Merck Sharp & Dohme LLC $57.63 11/29/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1048252513 Merck Sharp & Dohme LLC $54.99 11/29/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1048252515 Merck Sharp & Dohme LLC $87.52 11/28/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1048252579 Merck Sharp & Dohme LLC $117.50 11/29/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1048252581 Merck Sharp & Dohme LLC $64.99 11/29/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1048252583 Merck Sharp & Dohme LLC $81.52 11/28/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1048252585 Merck Sharp & Dohme LLC $325.50 11/29/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1048360409 Merck Sharp & Dohme LLC $150.00 12/11/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1048360413 Merck Sharp & Dohme LLC $2,610.00 12/11/2023 Consulting Fee Undisputed 01/23/2026 View at CMS
1055562577 Takeda Pharmaceuticals U.S.A., Inc. $6,900.00 03/20/2023 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.